MedPath

Ethaselen

Generic Name
Ethaselen
Drug Type
Small Molecule
Chemical Formula
C16H12N2O2Se2
CAS Number
217798-39-5
Unique Ingredient Identifier
4Q2EZS1IWG

Overview

Ethaselen is under investigation in clinical trial NCT02166242 (Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers).

Background

Ethaselen is under investigation in clinical trial NCT02166242 (Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath